Transdermal Drug Patches Market Report

Europe Transdermal Drug Patches Market Size, Status and Forecast 2014-2026

  • POSTDATE：Feb 20, 2020
  • PAGES：218
  • REPORT CODE：GMM478807
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Transdermal Drug Patches market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Transdermal Drug Patches Market Segmentations:

    By Player:

    • Immune Pharmaceuticals

    • Agile Therapeutics

    • Teikoku Pharma USA

    • Novartis

    • Pocono

    • Noven

    • Mylan

    • Xel Pharmaceuticals

    • DURECT Corporation

    • Johnson & Johnson

    • Hercon Pharmaceuticals

    By Type:

    • Fentanyl Transdermal Patch

    • Nicotine Transdermal Patch

    • Buprenorphine Transdermal Patch

    • Clonidine Transdermal Patch

    • Oxybutynin Transdermal Patch

    • Others

    By End-User:

    • Used for Hypertension

    • Used for Contraception

    • Used for Analgesia

    • Used for Smoking Cessation

    • Used for Angina

    • Used for Hormone Replacement

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Transdermal Drug Patches Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Transdermal Drug Patches Market Size and Growth Rate of Fentanyl Transdermal Patch from 2014 to 2026

    • 1.3.2 Europe Transdermal Drug Patches Market Size and Growth Rate of Nicotine Transdermal Patch from 2014 to 2026

    • 1.3.3 Europe Transdermal Drug Patches Market Size and Growth Rate of Buprenorphine Transdermal Patch from 2014 to 2026

    • 1.3.4 Europe Transdermal Drug Patches Market Size and Growth Rate of Clonidine Transdermal Patch from 2014 to 2026

    • 1.3.5 Europe Transdermal Drug Patches Market Size and Growth Rate of Oxybutynin Transdermal Patch from 2014 to 2026

    • 1.3.6 Europe Transdermal Drug Patches Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Transdermal Drug Patches Market Size and Growth Rate of Used for Hypertension from 2014 to 2026

    • 1.4.2 Europe Transdermal Drug Patches Market Size and Growth Rate of Used for Contraception from 2014 to 2026

    • 1.4.3 Europe Transdermal Drug Patches Market Size and Growth Rate of Used for Analgesia from 2014 to 2026

    • 1.4.4 Europe Transdermal Drug Patches Market Size and Growth Rate of Used for Smoking Cessation from 2014 to 2026

    • 1.4.5 Europe Transdermal Drug Patches Market Size and Growth Rate of Used for Angina from 2014 to 2026

    • 1.4.6 Europe Transdermal Drug Patches Market Size and Growth Rate of Used for Hormone Replacement from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Transdermal Drug Patches Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Transdermal Drug Patches by Major Types

      • 3.4.1 Market Size and Growth Rate of Fentanyl Transdermal Patch

      • 3.4.2 Market Size and Growth Rate of Nicotine Transdermal Patch

      • 3.4.3 Market Size and Growth Rate of Buprenorphine Transdermal Patch

      • 3.4.4 Market Size and Growth Rate of Clonidine Transdermal Patch

      • 3.4.5 Market Size and Growth Rate of Oxybutynin Transdermal Patch

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Transdermal Drug Patches Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Transdermal Drug Patches by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Transdermal Drug Patches for Used for Hypertension

      • 4.4.2 Market Size and Growth Rate of Transdermal Drug Patches for Used for Contraception

      • 4.4.3 Market Size and Growth Rate of Transdermal Drug Patches for Used for Analgesia

      • 4.4.4 Market Size and Growth Rate of Transdermal Drug Patches for Used for Smoking Cessation

      • 4.4.5 Market Size and Growth Rate of Transdermal Drug Patches for Used for Angina

      • 4.4.6 Market Size and Growth Rate of Transdermal Drug Patches for Used for Hormone Replacement

    5 Market Analysis by Major Regions

    • 5.1 Europe Transdermal Drug Patches Production Analysis by Top Regions

    • 5.2 Europe Transdermal Drug Patches Consumption Analysis by Top Regions

    • 5.3 Europe Transdermal Drug Patches Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Transdermal Drug Patches Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Transdermal Drug Patches Production, Import, Consumption and Export Analysis

      • 5.3.3 France Transdermal Drug Patches Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Transdermal Drug Patches Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Transdermal Drug Patches Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Transdermal Drug Patches Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Transdermal Drug Patches Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Transdermal Drug Patches Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Transdermal Drug Patches Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transdermal Drug Patches Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Transdermal Drug Patches Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Transdermal Drug Patches Production, Import, Consumption and Export Analysis

    6 Product Circulation of Transdermal Drug Patches Market among Top Countries

    • 6.1 Top 5 Export Countries in Transdermal Drug Patches Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Transdermal Drug Patches Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Transdermal Drug Patches Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Transdermal Drug Patches Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Transdermal Drug Patches Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Transdermal Drug Patches Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Transdermal Drug Patches Landscape Analysis

    • 7.1 Germany Transdermal Drug Patches Landscape Analysis by Major Types

    • 7.2 Germany Transdermal Drug Patches Landscape Analysis by Major End-Users

    8. UK Transdermal Drug Patches Landscape Analysis

    • 8.1 UK Transdermal Drug Patches Landscape Analysis by Major Types

    • 8.2 UK Transdermal Drug Patches Landscape Analysis by Major End-Users

    9. France Transdermal Drug Patches Landscape Analysis

    • 9.1 France Transdermal Drug Patches Landscape Analysis by Major Types

    • 9.2 France Transdermal Drug Patches Landscape Analysis by Major End-Users

    10. Italy Transdermal Drug Patches Landscape Analysis

    • 10.1 Italy Transdermal Drug Patches Landscape Analysis by Major Types

    • 10.2 Italy Transdermal Drug Patches Landscape Analysis by Major End-Users

    11. Spain Transdermal Drug Patches Landscape Analysis

    • 11.1 Spain Transdermal Drug Patches Landscape Analysis by Major Types

    • 11.2 Spain Transdermal Drug Patches Landscape Analysis by Major End-Users

    12. Poland Transdermal Drug Patches Landscape Analysis

    • 12.1 Poland Transdermal Drug Patches Landscape Analysis by Major Types

    • 12.2 Poland Transdermal Drug Patches Landscape Analysis by Major End-Users

    13. Russia Transdermal Drug Patches Landscape Analysis

    • 13.1 Russia Transdermal Drug Patches Landscape Analysis by Major Types

    • 13.2 Russia Transdermal Drug Patches Landscape Analysis by Major End-Users

    14. Switzerland Transdermal Drug Patches Landscape Analysis

    • 14.1 Switzerland Transdermal Drug Patches Landscape Analysis by Major Types

    • 14.2 Switzerland Transdermal Drug Patches Landscape Analysis by Major End-Users

    15. Turkey Transdermal Drug Patches Landscape Analysis

    • 15.1 Turkey Transdermal Drug Patches Landscape Analysis by Major Types

    • 15.2 Turkey Transdermal Drug Patches Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transdermal Drug Patches Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transdermal Drug Patches Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transdermal Drug Patches Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transdermal Drug Patches Landscape Analysis by Top Countries

      • 16.3.1 Denmark Transdermal Drug Patches Market Volume and Growth Rate

      • 16.3.2 Finland Transdermal Drug Patches Market Volume and Growth Rate

      • 16.3.3 Norway Transdermal Drug Patches Market Volume and Growth Rate

      • 16.3.4 Sweden Transdermal Drug Patches Market Volume and Growth Rate

      • 16.3.6 Iceland Transdermal Drug Patches Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Transdermal Drug Patches Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Transdermal Drug Patches Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Transdermal Drug Patches Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Transdermal Drug Patches Landscape Analysis by Top Countries

      • 17.3.1 Belgium Transdermal Drug Patches Market Volume and Growth Rate

      • 17.3.2 Netherlands Transdermal Drug Patches Market Volume and Growth Rate

      • 17.3.3 Luxembourg Transdermal Drug Patches Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Transdermal Drug Patches Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Transdermal Drug Patches Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Transdermal Drug Patches Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Transdermal Drug Patches Landscape Analysis by Top Countries

      • 18.3.1 Estonia Transdermal Drug Patches Market Volume and Growth Rate

      • 18.3.2 Latvia Transdermal Drug Patches Market Volume and Growth Rate

      • 18.3.3 Lithuania Transdermal Drug Patches Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Immune Pharmaceuticals

      • 19.1.1 Immune Pharmaceuticals Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Agile Therapeutics

      • 19.2.1 Agile Therapeutics Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Teikoku Pharma USA

      • 19.3.1 Teikoku Pharma USA Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Novartis

      • 19.4.1 Novartis Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Pocono

      • 19.5.1 Pocono Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Noven

      • 19.6.1 Noven Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Mylan

      • 19.7.1 Mylan Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Xel Pharmaceuticals

      • 19.8.1 Xel Pharmaceuticals Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 DURECT Corporation

      • 19.9.1 DURECT Corporation Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Johnson & Johnson

      • 19.10.1 Johnson & Johnson Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Hercon Pharmaceuticals

      • 19.11.1 Hercon Pharmaceuticals Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    The List of Tables and Figures (Totals 85 Figures and 128 Tables)

    • Figure Product Picture

    • Figure Europe Transdermal Drug Patches Market Size and Growth Rate of Fentanyl Transdermal Patch from 2014 to 2026

    • Figure Europe Transdermal Drug Patches Market Size and Growth Rate of Nicotine Transdermal Patch from 2014 to 2026

    • Figure Europe Transdermal Drug Patches Market Size and Growth Rate of Buprenorphine Transdermal Patch from 2014 to 2026

    • Figure Europe Transdermal Drug Patches Market Size and Growth Rate of Clonidine Transdermal Patch from 2014 to 2026

    • Figure Europe Transdermal Drug Patches Market Size and Growth Rate of Oxybutynin Transdermal Patch from 2014 to 2026

    • Figure Europe Transdermal Drug Patches Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Transdermal Drug Patches Market Size and Growth Rate of Used for Hypertension from 2014 to 2026

    • Figure Europe Transdermal Drug Patches Market Size and Growth Rate of Used for Contraception from 2014 to 2026

    • Figure Europe Transdermal Drug Patches Market Size and Growth Rate of Used for Analgesia from 2014 to 2026

    • Figure Europe Transdermal Drug Patches Market Size and Growth Rate of Used for Smoking Cessation from 2014 to 2026

    • Figure Europe Transdermal Drug Patches Market Size and Growth Rate of Used for Angina from 2014 to 2026

    • Figure Europe Transdermal Drug Patches Market Size and Growth Rate of Used for Hormone Replacement from 2014 to 2026

    • Figure Germany Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure UK Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure France Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Transdermal Drug Patches Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Transdermal Drug Patches Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Transdermal Drug Patches

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Transdermal Drug Patches by Different Types from 2014 to 2026

    • Table Consumption Share of Transdermal Drug Patches by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Fentanyl Transdermal Patch

    • Figure Market Size and Growth Rate of Nicotine Transdermal Patch

    • Figure Market Size and Growth Rate of Buprenorphine Transdermal Patch

    • Figure Market Size and Growth Rate of Clonidine Transdermal Patch

    • Figure Market Size and Growth Rate of Oxybutynin Transdermal Patch

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Transdermal Drug Patches by Different End-Users from 2014 to 2026

    • Table Consumption Share of Transdermal Drug Patches by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Used for Hypertension

    • Figure Market Size and Growth Rate of Used for Contraception

    • Figure Market Size and Growth Rate of Used for Analgesia

    • Figure Market Size and Growth Rate of Used for Smoking Cessation

    • Figure Market Size and Growth Rate of Used for Angina

    • Figure Market Size and Growth Rate of Used for Hormone Replacement

    • Table Europe Transdermal Drug Patches Production by Major Regions

    • Table Europe Transdermal Drug Patches Production Share by Major Regions

    • Figure Europe Transdermal Drug Patches Production Share by Major Countries and Regions in 2014

    • Table Europe Transdermal Drug Patches Consumption by Major Regions

    • Table Europe Transdermal Drug Patches Consumption Share by Major Regions

    • Table Germany Transdermal Drug Patches Production, Import, Consumption and Export Analysis

    • Table UK Transdermal Drug Patches Production, Import, Consumption and Export Analysis

    • Table France Transdermal Drug Patches Production, Import, Consumption and Export Analysis

    • Table Italy Transdermal Drug Patches Production, Import, Consumption and Export Analysis

    • Table Spain Transdermal Drug Patches Production, Import, Consumption and Export Analysis

    • Table Poland Transdermal Drug Patches Production, Import, Consumption and Export Analysis

    • Table Russia Transdermal Drug Patches Production, Import, Consumption and Export Analysis

    • Table Switzerland Transdermal Drug Patches Production, Import, Consumption and Export Analysis

    • Table Turkey Transdermal Drug Patches Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transdermal Drug Patches Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Transdermal Drug Patches Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Transdermal Drug Patches Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Transdermal Drug Patches Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Transdermal Drug Patches Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Transdermal Drug Patches Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Transdermal Drug Patches Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Germany Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Table Germany Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Germany Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Table UK Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table UK Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Table UK Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table UK Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Table France Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table France Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Table France Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table France Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Table Italy Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Italy Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Table Italy Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Italy Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Table Spain Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Spain Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Table Spain Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Spain Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Table Poland Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Poland Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Table Poland Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Poland Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Table Russia Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Russia Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Table Russia Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Russia Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Switzerland Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Table Switzerland Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Switzerland Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Turkey Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Table Turkey Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Turkey Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transdermal Drug Patches Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Transdermal Drug Patches Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Transdermal Drug Patches Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Transdermal Drug Patches Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Transdermal Drug Patches Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Transdermal Drug Patches Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Transdermal Drug Patches Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Transdermal Drug Patches Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Transdermal Drug Patches Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Transdermal Drug Patches Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Transdermal Drug Patches Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Transdermal Drug Patches Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Transdermal Drug Patches Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Transdermal Drug Patches Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Transdermal Drug Patches Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Transdermal Drug Patches Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Transdermal Drug Patches Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Transdermal Drug Patches Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Transdermal Drug Patches Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Transdermal Drug Patches Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Transdermal Drug Patches Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Immune Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immune Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Immune Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Immune Pharmaceuticals

    • Table Product and Service Introduction of Immune Pharmaceuticals

    • Table Company Profile and Development Status of Agile Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agile Therapeutics

    • Figure Sales and Growth Rate Analysis of Agile Therapeutics

    • Figure Revenue and Market Share Analysis of Agile Therapeutics

    • Table Product and Service Introduction of Agile Therapeutics

    • Table Company Profile and Development Status of Teikoku Pharma USA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teikoku Pharma USA

    • Figure Sales and Growth Rate Analysis of Teikoku Pharma USA

    • Figure Revenue and Market Share Analysis of Teikoku Pharma USA

    • Table Product and Service Introduction of Teikoku Pharma USA

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Pocono

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pocono

    • Figure Sales and Growth Rate Analysis of Pocono

    • Figure Revenue and Market Share Analysis of Pocono

    • Table Product and Service Introduction of Pocono

    • Table Company Profile and Development Status of Noven

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Noven

    • Figure Sales and Growth Rate Analysis of Noven

    • Figure Revenue and Market Share Analysis of Noven

    • Table Product and Service Introduction of Noven

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Xel Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Xel Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Xel Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Xel Pharmaceuticals

    • Table Product and Service Introduction of Xel Pharmaceuticals

    • Table Company Profile and Development Status of DURECT Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of DURECT Corporation

    • Figure Sales and Growth Rate Analysis of DURECT Corporation

    • Figure Revenue and Market Share Analysis of DURECT Corporation

    • Table Product and Service Introduction of DURECT Corporation

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Hercon Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hercon Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Hercon Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Hercon Pharmaceuticals

    • Table Product and Service Introduction of Hercon Pharmaceuticals

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US